4-butyrolactone has been researched along with Chronic Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bauck, AG; Gilliam, LL; Kembel, SL; Schoonover, MJ; Taylor, JD; Young, JM | 1 |
| Carlot, S; Chatelain, P; Dumont, JE; Hassid, S; Tarabichi, M; Veithen, A; Verbeurgt, C | 1 |
| Chang, YQ; Chen, WM; Lin, J; Liu, J; Sun, PH; Wang, F; Xu, XJ; Zeng, T | 1 |
| Eichholzer, M; Linseisen, J; Nicastro, HL; Platz, EA; Richard, A; Rohrmann, S | 1 |
| Aquino, M; Bruno, I; Guerrero, MD; Payá, M; Riccio, R; Terencio, MC | 1 |
| Bastos, JK; Costa, ES; da Silva Ferreira, D; de Albuquerque, S; Esperandim, VR; Pereira, AC; Saraiva, J; Silva, ML | 1 |
| Givskov, M; Hentzer, M | 1 |
| Kim, EK; Kuhajda, FP; Moran, TH; Ronnett, GV; Thupari, JN | 1 |
| Alcaraz, MJ; De Giulio, A; De Rosa, S; García Pastor, P; Payá, M | 1 |
| Eberl, L; Geisenberger, O; Givskov, M; Høiby, N; Riedel, K; Tümmler, B | 1 |
| Adlercreutz, H; Kilkkinen, A; Klaukka, T; Korhonen, P; Pietinen, P; Virtamo, J | 1 |
1 review(s) available for 4-butyrolactone and Chronic Disease
| Article | Year |
|---|---|
Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Chronic Disease; Furans; Humans; Signal Transduction | 2003 |
1 trial(s) available for 4-butyrolactone and Chronic Disease
| Article | Year |
|---|---|
Efficacy of orally administered gabapentin in horses with chronic thoracic limb lameness.
Topics: 4-Butyrolactone; Analgesics; Animals; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Gabapentin; Horse Diseases; Horses; Lameness, Animal; Male; Sulfones | 2020 |
9 other study(ies) available for 4-butyrolactone and Chronic Disease
| Article | Year |
|---|---|
The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds.
Topics: 4-Butyrolactone; Antigens, Bacterial; Chronic Disease; Dimethyl Sulfoxide; HEK293 Cells; Humans; Immunity, Innate; Quorum Sensing; Receptors, G-Protein-Coupled; Rhinitis; Sinusitis; Staphylococcus aureus; Streptococcus pneumoniae | 2017 |
4-arylamidobenzyl substituted 5-bromomethylene-2(5H)-furanones for chronic bacterial infection.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Humans; Lipopolysaccharides; Male; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide; PPAR gamma; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; RAW 264.7 Cells | 2018 |
Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008.
Topics: 4-Butyrolactone; Adult; Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Cross-Sectional Studies; Female; Humans; Inflammation; Leukocyte Count; Lignans; Male; Middle Aged; Nutrition Surveys; United States | 2014 |
Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
Topics: 4-Butyrolactone; Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Behavior, Animal; Blood Platelets; Cattle; Chronic Disease; Gene Expression Regulation, Enzymologic; Humans; Hyperalgesia; Inflammation; Intramolecular Oxidoreductases; Leukotriene B4; Male; Mice; Neutrophils; Prostaglandin-E Synthases; Thiophenes; Thromboxane B2 | 2009 |
Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; beta-Galactosidase; Chagas Disease; Chronic Disease; Dioxoles; Heart; Karyometry; Lactones; Lignans; Liver; Mice; Mice, Inbred BALB C; Spleen; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Topics: 4-Butyrolactone; Adipose Tissue; Animals; Body Weight; Carnitine O-Palmitoyltransferase; Chronic Disease; Diet; Eating; Fatty Acid Synthases; Fatty Acids; Fatty Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Treatment Outcome | 2004 |
Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Infective Agents; Arthritis, Experimental; Chronic Disease; Dose-Response Relationship, Drug; Ear; Edema; Enzymes; Female; Humans; Inflammation; Leukocytes; Male; Mice; Phospholipases A; Phospholipases A2; Pyrans; Rats; Rats, Wistar; Synovial Fluid; U937 Cells | 1999 |
Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.
Topics: 4-Butyrolactone; Burkholderia cepacia; Burkholderia Infections; Chromatography, Thin Layer; Chronic Disease; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Humans; Lung Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Signal Transduction | 2000 |
Use of oral antimicrobials decreases serum enterolactone concentration.
Topics: 4-Butyrolactone; Administration, Oral; Adult; Anti-Bacterial Agents; Biomarkers; Chronic Disease; Cross-Sectional Studies; Digestive System; Female; Humans; Lignans; Middle Aged; Risk Factors | 2002 |